Sotera Health Company (SHC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
8 Apr, 2026Voting matters and shareholder proposals
Four Class III director nominees are up for election to serve until the 2029 Annual Meeting of Stockholders.
Advisory approval of named executive officer compensation is on the agenda.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, is proposed.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Annual Meeting will be held virtually on May 21, 2026, at 9:00 a.m. EDT.
Executive compensation and say-on-pay
Advisory vote on executive compensation for named executive officers is included.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Sotera Health Company
- 2025 delivered record revenue and margin growth; 2026 guidance projects further gains.SHC
Q4 202513 Apr 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and governance updates.SHC
Proxy filing8 Apr 2026 - 2026 guidance targets 5%-6.5% growth, with strong momentum and disciplined capital allocation.SHC
2026 KeyBanc Capital Markets Healthcare Forum20 Mar 2026 - Strong growth, stable demand, and proactive regulatory and legal management define the outlook.SHC
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Targeting 5%-7% annual growth and $500M+ free cash flow, driven by strategic market focus.SHC
Investor Day 20243 Feb 2026 - Q3 2024 saw 8.5% revenue growth, margin expansion, and improved leverage amid strong liquidity.SHC
Q3 20243 Feb 2026 - Q2 net revenues up 8.3%, EBITDA up 7%, but net income fell on refinancing and interest costs.SHC
Q2 20242 Feb 2026 - Volume recovery, regulatory compliance, and CapEx discipline support growth and margin rebound.SHC
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Surpassed $1.16B revenue in 2025, with strong growth, margins, and strategic execution.SHC
44th Annual J.P. Morgan Healthcare Conference12 Jan 2026